Literature DB >> 7995157

Biofeedback training is useful in fecal incontinence but disappointing in constipation.

J O Keck1, R J Staniunas, J A Coller, R C Barrett, M E Oster, D J Schoetz, P L Roberts, J J Murray, M C Veidenheimer.   

Abstract

BACKGROUND: Successful biofeedback therapy has been reported in the treatment of fecal incontinence and constipation. It is uncertain which groups of incontinent patients benefit from biofeedback, and our impression has been that biofeedback is more successful for incontinence than for constipation.
PURPOSE: This study was designed to review the results of biofeedback therapy at the Lahey Clinic.
METHODS: Biofeedback was performed using an eight-channel, water-perfused manometry system. Patients saw anal canal pressures as a color bar graph on a computer screen. Assessment after biofeedback was by manometry and by telephone interview with an independent researcher.
RESULTS: Fifteen patients (13 women and 2 men) with incontinence underwent a mean of three (range, 1-7) biofeedback sessions. The cause was obstetric (four patients), postsurgical (five patients), and idiopathic (six patients). Complete resolution of symptoms was reported in four patients, considerable improvement in four patients, and some improvement in three patients. Manometry showed a mean increase of 15.3 (range, -3-30) mmHg in resting pressure and 35.7 (range, 13-57) mmHg in squeezing pressure after biofeedback. A successful outcome could not be predicted on the basis of cause, severity of incontinence, or initial manometry. Twelve patients (10 women and 2 men) with constipation underwent a mean of three (range, 1-14) biofeedback sessions. Each had manometric evidence of paradoxic nonrelaxing external sphincter or puborectalis muscle confirmed by defography or electromyography. All patients could be taught to relax their sphincter in response to bearing down. Despite this, only one patient reported resolution of symptoms, three patients had reduced straining, and three patients had some gain in insight.
CONCLUSIONS: Biofeedback helped 73 percent of patients with fecal incontinence, and its use should be considered regardless of the cause or severity of incontinence or of results on initial manometry. In contrast, biofeedback directed at correcting paradoxic external sphincter contraction has been disappointing.

Entities:  

Mesh:

Year:  1994        PMID: 7995157     DOI: 10.1007/BF02257795

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  7 in total

Review 1.  Bio-feedback treatment of fecal incontinence: where are we, and where are we going?

Authors:  Giuseppe Chiarioni; Barbara Ferri; Antonio Morelli; Guido Iantorno; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

Review 2.  Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes.

Authors:  Julie Ann M Van Koughnett; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 3.  Biofeedback therapy for dyssynergic defecation.

Authors:  Giuseppe Chiarioni; Steve Heymen; William-E Whitehead
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

4.  Effects of biofeedback therapy on anorectal function in obstructive defecation.

Authors:  S S Rao; K D Welcher; R E Pelsang
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

Review 5.  Biofeedback treatment of chronic constipation: myths and misconceptions.

Authors:  G Chiarioni
Journal:  Tech Coloproctol       Date:  2016-07-22       Impact factor: 3.781

6.  Customized biofeedback therapy improves results in fecal incontinence.

Authors:  Maria del Carmen Martínez-Puente; José Antonio Pascual-Montero; Damián García-Olmo
Journal:  Int J Colorectal Dis       Date:  2003-10-07       Impact factor: 2.571

7.  Biofeedback therapy plus anal electrostimulation for fecal incontinence: prognostic factors and effects on anorectal physiology.

Authors:  Adamo Stefano Boselli; Ferdinando Pinna; Stefano Cecchini; Renato Costi; Federico Marchesi; Vincenzo Violi; Leopoldo Sarli; Luigi Roncoroni
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.